Prostaglandin receptors are mediators of vascular function in endometrial pathologies

Abberton, 1996, Vascular smooth muscle alpha-actin distribution around endometrial arterioles during the menstrual cycle: increased expression during the perimenopause and lack of correlation with menorrhagia, Hum. Reprod., 11, 204, 10.1093/oxfordjournals.humrep.a019020 Abberton, 1999, Vascular smooth muscle cell proliferation in arterioles of the human endometrium, Hum. Reprod., 14, 1072, 10.1093/humrep/14.4.1072 Adelantado, 1988, Increased uterine prostaglandin E receptors in menorrhagic women, Br. J. Obstet. Gynaecol., 95, 162, 10.1111/j.1471-0528.1988.tb06846.x Anderson, 1976, Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors, Lancet, 1, 774, 10.1016/S0140-6736(76)91612-3 Bartosik, 1986, Endometrial tissue in peritoneal fluid, Fert. Steril., 46, 796, 10.1016/S0015-0282(16)49813-4 Battersby, 2004, Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle, J. Clin. Endocrinol. Metab., 89, 2463, 10.1210/jc.2003-032012 Bley, 1998, The role of IP prostanoid receptors in inflammatory pain, Trends Pharmacol. Sci., 19, 141, 10.1016/S0165-6147(98)01185-7 Blumenthal, 2002, Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium, Fert. Steril., 78, 1294, 10.1016/S0015-0282(02)04276-0 Brenner, 2002, Premenstrual and menstrual changes in the macaque and human endometrium: relevance to endometriosis, Ann. NY Acad. Sci., 955, 60, 10.1111/j.1749-6632.2002.tb02766.x Brosens, 2000, Mechanisms of dysmenorrhoea, 113 Buttram, 1981, Uterine leiomyomata: etiology, symptomatology, and management, Fert. Steril., 36, 433, 10.1016/S0015-0282(16)45789-4 Cameron, 1989, Dysfunctional uterine bleeding, Baillieres Clin. Obstet. Gynaecol., 3, 315, 10.1016/S0950-3552(89)80024-0 Cameron, 1990, The effects of mefenamic acid and norethisterone on measured menstrual blood loss, Obstet. Gynecol., 76, 85 Chandrasekharan, 2002, COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression, Proc. Natl. Acad. Sci. U.S.A., 99, 13926, 10.1073/pnas.162468699 Chiazze, 1968, The length and variability of the human menstrual cycle, JAMA, 203, 377, 10.1001/jama.203.6.377 Chimbira, 1980, Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area, Br. J. Obstet. Gynaecol., 87, 603, 10.1111/j.1471-0528.1980.tb05013.x Chu, 1996, Localization of seminal plasma transforming growth factor-beta1 on human spermatozoa: an immunocytochemical study, Fert. Steril., 66, 327, 10.1016/S0015-0282(16)58461-1 Chulada, 2000, Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice, Cancer Res., 60, 4705 Collisson, 2003, Treatment of metastatic melanoma with an orally available inhibitor of the Ras–Raf–MAPK Cascade, Cancer Res., 63, 5669 Coulter, 1988, Do British women undergo too many or too few hysterectomies?, Soc. Sci. Med., 27, 987, 10.1016/0277-9536(88)90289-4 Critchley, 1994, Endometrial sex steroid receptor expression in women with menorrhagia, Br. J. Obstet. Gynaecol., 101, 428, 10.1111/j.1471-0528.1994.tb11917.x Critchley, 2001, Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium, J. Clin. Endocrinol. Metab., 86, 1370, 10.1210/jc.86.3.1370 Critchley, 2001, The endocrinology of menstruation—a role for the immune system, Clin. Endocrinol., 55, 701, 10.1046/j.1365-2265.2001.01432.x Critchley, 1999, Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy, J. Clin. Endocrinol. Metab., 84, 240, 10.1210/jc.84.1.240 Daniels, 2002, Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea, Obstet. Gynecol., 100, 350, 10.1016/S0029-7844(02)02085-9 Davis, 1999, Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta, Endocrinology, 140, 2685, 10.1210/en.140.6.2685 Dawood, 1985, Dysmenorrhea, J. Reprod. Med., 30, 154 Dinchuk, 1995, Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II, Nature, 378, 406, 10.1038/378406a0 Dore, 1998, Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas, J. Histochem. Cytochem., 46, 77, 10.1177/002215549804600110 Eldred, 1994, Pituitary and ovarian hormone levels in unexplained menorrhagia, Obstet. Gynecol., 84, 775 Ellenson, 2004, Focus on endometrial and cervical cancer, Cancer Cell, 5, 533, 10.1016/j.ccr.2004.05.029 Ferrandina, 2002, Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome, Cancer, 95, 801, 10.1002/cncr.10736 Fosslien, 1998, Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system, Ann. Clin. Lab. Sci., 28, 67 Fraser, 1992, Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders, Baillieres Clin. Obstet. Gynaecol., 6, 829, 10.1016/S0950-3552(05)80191-9 Fraser, 1981, Efficacy of mefenamic acid in patients with a complaint of menorrhagia, Obstet. Gynecol., 58, 543 Fujino, 2003, Prostaglandin F2α stimulation of cyclooxygenase-2 promoter activity by the FPB prostanoid receptor, Eur. J. Pharmacol., 465, 39, 10.1016/S0014-2999(03)01485-7 Gargett, 2001, Human endometrial angiogenesis, Reproduction, 121, 181, 10.1530/rep.0.1210181 Gazvani, 2002, Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis, Reproduction, 123, 217, 10.1530/rep.0.1230217 Gordon, 1994, Pathology of hyperplasia and carcinoma of the endometrium, Semin. Oncol., 21, 64 Graham, 2005, Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study, Lancet, 365, 475, 10.1016/S0140-6736(05)17864-7 Gross, 1998, Opposing actions of prostaglandins and oxytocin determine the onset of murine labor, Proc. Natl. Acad. Sci. U.S.A., 95, 11875, 10.1073/pnas.95.20.11875 Gutsche, 2003, Seminal plasma induces mRNA expression of IL-1beta, IL-6 and LIF in endometrial epithelial cells in vitro, Mol. Hum. Reprod., 9, 785, 10.1093/molehr/gag095 Hallberg, 1966, Menstrual blood loss—a population study. Variation at different ages and attempts to define normality, Acta Obstet. Gynecol. Scand., 45, 320, 10.3109/00016346609158455 Hewett, 2002, Down-regulation of angiopoietin-1 expression in menorrhagia, Am. J. Pathol., 160, 773, 10.1016/S0002-9440(10)64899-7 Hickey, 2000, Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding, Hum. Reprod., 15, 1509, 10.1093/humrep/15.7.1509 Hizaki, 1999, Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2, Proc. Natl. Acad. Sci. U.S.A., 96, 10501, 10.1073/pnas.96.18.10501 Hwang, 1998, Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer, J. Natl. Cancer Inst., 90, 455, 10.1093/jnci/90.6.455 Jabbour, 2001, Expression of COX-2 and PGE synthase and synthesis of PGE2 in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors, Br. J. Cancer, 85, 1023, 10.1054/bjoc.2001.2033 Jones, 1997, Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation, Hum. Reprod., 12, 1300, 10.1093/humrep/12.6.1300 Kang, 2005, Expression of human prostaglandin transporter in the human endometrium across the menstrual cycle, J. Clin. Endocrinol. Metab., 90, 2308, 10.1210/jc.2004-1482 Karck, 1996, PGE2 and PGF2α release by human peritoneal macrophages in endometriosis, Prostaglandins, 51, 49, 10.1016/0090-6980(95)00159-X Kedar, 2002, Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice, Clin. Cancer Res., 8, 3592 Kennedy, 1999, Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor, Nat. Med., 5, 217, 10.1038/7426 Kirschenbaum, 2000, Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate, Urology, 56, 671, 10.1016/S0090-4295(00)00674-9 Kitamura, 2002, Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis, Carcinogenesis, 23, 1463, 10.1093/carcin/23.9.1463 Kooy, 1996, Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation, Hum. Reprod., 11, 1067, 10.1093/oxfordjournals.humrep.a019298 Kouides, 2001, Obstetric and gynaecological aspects of von Willebrand disease, Best Pract. Res. Clin. Haematol., 14, 381, 10.1053/beha.2001.0140 Kulkarni, 2001, Cyclooxygenase-2 is overexpressed in human cervical cancer, Clin. Cancer Res., 7, 429 Kunz, 1997, The uterine peristaltic pump. Normal and impeded sperm transport within the female genital tract, Adv. Exp. Med. Biol., 424, 267, 10.1007/978-1-4615-5913-9_49 Kunz, 2002, Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction, Reprod. Biomed. Online, 4, 5, 10.1016/S1472-6483(12)60108-4 Langenbach, 1999, Cyclooxygenase knockout mice: models for elucidating isoform-specific functions, Biochem. Pharmacol., 58, 1237, 10.1016/S0006-2952(99)00158-6 Langenbach, 1999, Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis, Ann. NY Acad. Sci., 889, 52, 10.1111/j.1749-6632.1999.tb08723.x Langenbach, 1995, Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration, Cell, 83, 483, 10.1016/0092-8674(95)90126-4 Lim, 1997, Multiple female reproductive failures in cyclooxygenase 2-deficient mice, Cell, 91, 197, 10.1016/S0092-8674(00)80402-X Livingstone, 2002, Mechanisms of abnormal uterine bleeding, Hum. Reprod. Update, 8, 60, 10.1093/humupd/8.1.60 Lockwood, 2004, Angiogenic factors and the endometrium following long term progestin only contraception, Histol. Histopathol., 19, 167 Lumsden, 1983, Primary dysmenorrhoea: the importance of both prostaglandins E2 and F2α, Br. J. Obstet. Gynaecol., 90, 1135, 10.1111/j.1471-0528.1983.tb06460.x Lundstrom, 1977, The myometrial response to intra-uterine administration of PGF2 alpha and PGE2 in dysmenorrheic women, Acta Obstet. Gynecol. Scand., 56, 167, 10.3109/00016347709162115 Lundstrom, 1978, Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors–a promising therapeutic alternative, Acta Obstet. Gynecol. Scand., 57, 421, 10.3109/00016347809156523 Lundstrom, 1976, Prostaglandins, indomethacin and dysmenorrhea, Prostaglandins, 11, 893, 10.1016/0090-6980(76)90196-9 Maisonpierre, 1997, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science, 277, 55, 10.1126/science.277.5322.55 Makarainen, 1986, Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen, Br. J. Obstet. Gynaecol., 93, 974, 10.1111/j.1471-0528.1986.tb08019.x Maldve, 2000, Prostaglandin E2 regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors, J. Lipid Res., 41, 873, 10.1016/S0022-2275(20)32029-0 Mant, 1994, Ovarian and endometrial cancers, Cancer Surv., 20, 287 Morita, 2002, Distinct functions of COX-1 and COX-2, Prostaglandins Other Lipid Mediat., 68/69, 165, 10.1016/S0090-6980(02)00029-1 Narko, 1997, Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression, J. Biol. Chem., 272, 21455, 10.1074/jbc.272.34.21455 Narumiya, 2001, Genetic and pharmacological analysis of prostanoid receptor function, J. Clin. Invest., 108, 25, 10.1172/JCI200113455 Narumiya, 1999, Prostanoid receptors: structures, properties, and functions, Physiol. Rev., 79, 1193, 10.1152/physrev.1999.79.4.1193 Noble, 1997, Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells, J. Clin. Endocrinol. Metab., 82, 600, 10.1210/jc.82.2.600 Oral, 1996, The peritoneal environment in endometriosis, Hum. Reprod. Update, 2, 385, 10.1093/humupd/2.5.385 Ota, 2001, Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis, Hum. Reprod., 16, 561, 10.1093/humrep/16.3.561 Parazzini, 1991, The epidemiology of endometrial cancer, Gynecol. Oncol., 41, 1, 10.1016/0090-8258(91)90246-2 Perchick, 2003, Cyclooxygenase-2 overexpression inhibits cathepsin D-mediated cleavage of plasminogen to the potent antiangiogenic factor angiostatin, Endocrinology, 144, 5322, 10.1210/en.2003-0986 Pickles, 1965, Prostaglandins in endometrium and menstrual fluid from normal and dysmenorrhoeic subjects, J. Obstet. Gynaecol. Br. Commonw., 72, 185, 10.1111/j.1471-0528.1965.tb01415.x Prentice, 1999, Health care implications of dysfunctional uterine bleeding, Baillieres Best Pract. Res. Clin. Obstet. Gynaecol., 13, 181, 10.1053/beog.1999.0016 Prentice, 2000, Health burden of menstrual disorders, 13 Rees, 1984, Endometrial and myometrial prostaglandin release during the menstrual cycle in relation to menstrual blood loss, J. Clin. Endocrinol. Metab., 58, 813, 10.1210/jcem-58-5-813 Rees, 1984, Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea, Br. J. Obstet. Gynaecol., 91, 673, 10.1111/j.1471-0528.1984.tb04829.x Rees, 1988, Effect of fenamates on prostaglandin E receptor binding, Lancet, 2, 541, 10.1016/S0140-6736(88)92660-8 Rees, 1989, Effect of inhibitors of prostaglandin synthesis on uterine prostaglandin E receptor binding, Br. J. Obstet. Gynaecol., 96, 1112, 10.1111/j.1471-0528.1989.tb03395.x Robertson, 2005, Seminal plasma and male factor signaling in the female reproductive tract, Cell Tiss. Res., 5, 1127 Ryu, 2000, High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion, Gynecol. Oncol., 76, 320, 10.1006/gyno.1999.5690 Sales, 2003, Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium, Reproduction, 126, 559, 10.1530/rep.0.1260559 Sales, 2003, Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology, Prostaglandins Other Lipid Mediat., 71, 97, 10.1016/S1098-8823(03)00050-9 Sales, 2001, Cyclooxygenase-2 expression and prostaglandin E2 synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors, J. Clin. Endocrinol. Metab., 86, 2243, 10.1210/jc.86.5.2243 Sales, 2002, Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, PGE receptors and angiogenic factors by cyclooxygenase-1, Cancer Res., 62, 424 Sales, 2002, Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signaling in cervical adenocarcinoma cells, Mol. Hum. Reprod., 8, 1065, 10.1093/molehr/8.12.1065 Sales, 2005, A novel angiogenic role for Prostaglandin F2a-FP receptor interaction in human endometrial adenocarcinoma, Cancer Research, 65, 1, 10.1158/0008-5472.CAN-05-0101 Sales, 2004, Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways, Mol. Endocrinol., 18, 1533, 10.1210/me.2004-0022 Sales, 2004, Expression, localization, and signaling of PGF2α receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways, J. Clin. Endocrinol. Metab., 89, 986, 10.1210/jc.2003-031434 Seno, 2002, Cyclooxygenase-2 and prostaglandin E2 receptor EP2-dependent angiogenesis in APC delta 716 mouse intestinal polyps, Cancer Res., 62, 506 Smith, 1998, Angiogenesis, vascular endothelial growth factor and the endometrium, Hum. Reprod. Update, 4, 509, 10.1093/humupd/4.5.509 Smith, 1981, Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding, Br. J. Obstet. Gynaecol., 88, 434, 10.1111/j.1471-0528.1981.tb01009.x Smith, 2000, Cyclooxygenases: structural, cellular, and molecular biology, Annu. Rev. Biochem., 69, 145, 10.1146/annurev.biochem.69.1.145 Sonoshita, 2001, Acceleration of intestinal polyposis through prostaglandin receptor EP2 in APC delta 714 knockout mice, Nat. Med., 7, 1048, 10.1038/nm0901-1048 Templeton, 1978, Prostaglandin concentrations in the semen of fertile men, J. Reprod. Fert., 52, 147, 10.1530/jrf.0.0520147 Tilley, 1999, Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor, J. Clin. Invest., 103, 1539, 10.1172/JCI6579 Tjandrawinata, 1997, Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells, Br. J. Cancer, 75, 1111, 10.1038/bjc.1997.192 Tjandrawinata, 1997, Up-regulation of cyclooxygenase-2 by product-prostaglandin E2, Adv. Exp. Med. Biol., 407, 163, 10.1007/978-1-4899-1813-0_25 Tong, 2000, Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma, Neoplasia, 2, 483, 10.1038/sj.neo.7900119 Torrance, 2000, Combinatorial chemoprevention of intestinal neoplasia, Nat. Med., 6, 1024, 10.1038/79534 Treloar, 1967, Variation of the human menstrual cycle through reproductive life, Int. J. Fert., 12, 77 Tsujii, 1998, Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell, 93, 705, 10.1016/S0092-8674(00)81433-6 Uotila, 2002, The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma, Ann. Med., 34, 428, 10.1080/078538902321012379 Vessey, 1992, The epidemiology of hysterectomy: findings in a large cohort study, Br. J. Obstet. Gynaecol., 99, 402, 10.1111/j.1471-0528.1992.tb13758.x Weston, 2000, Endometrial angiogenesis, Baillieres Best Pract. Res. Clin. Obstet. Gynaecol., 14, 919, 10.1053/beog.2000.0135 Willman, 1976, Studies in the involvement of prostaglandins in uterine symptomatology and pathology, Br. J. Obstet. Gynaecol., 83, 337, 10.1111/j.1471-0528.1976.tb00839.x Wingo, 1995, Cancer statistics, 1995, Cancer J. Clin., 45, 8, 10.3322/canjclin.45.1.8 Zervou, 1999, Nitric oxide synthase expression and steroid regulation in the uterus of women with menorrhagia, Mol. Hum. Reprod., 5, 1048, 10.1093/molehr/5.11.1048